Two Distinct Immune Cell Signatures Predict the Clinical Outcomes in Patients With Amyopathic Dermatomyositis With Interstitial Lung Disease-Reference-Cited by-同舟云学术

Two Distinct Immune Cell Signatures Predict the Clinical Outcomes in Patients With Amyopathic Dermatomyositis With Interstitial Lung Disease

Published:2022-10-03 Issue:11 Volume:74 Page:1822-1832
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Ye Yan¹,Zhang Xueliang¹,Li Teng²,Ma Jiaqiang²,Wang Ran¹^ORCID,Wu Chunmei¹,Wang Runci¹^ORCID,Bao Chunde¹^ORCID,Ye Shuang¹,Shen Nan¹^ORCID,Guo Qiang¹,Fu Qiong¹^ORCID,Zhang Xiaoming³

Affiliation:

1. Department of Rheumatology, Renji Hospital Shanghai Jiaotong University School of Medicine Shanghai China

2. The Center for Microbes, Development and Health, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai Chinese Academy of Sciences/University of Chinese Academy of Sciences Shanghai China

3. The Center for Microbes, Development and Health, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai Chinese Academy of Sciences/University of Chinese Academy of Sciences, and Shanghai Huashen Institute of Microbes and Infections Shanghai China

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.42264

Reference37 articles.

1. Classification and management of adult inflammatory myopathies

2. Mortality Risk Prediction in Amyopathic Dermatomyositis Associated With Interstitial Lung Disease